Sara A. Dudley

TL;DR: Deterministic sensitivity analysis showed that THP in patients with metastatic HER2-positive breast cancer is unlikely to be cost effective in the United States, and probabilistic sensitivity analysis predicted 0% chance of cost effectiveness at a willingness to pay of $100,000 per QALY gained.

TL;DR: Because it is fully automated, the model can be used to examine providers' practice patterns and could be deployed in a decision support tool to help improve quality of care.

TL;DR: Patients with elevated pre-SABR non- target lung FDG-PET uptake are at increased risk of symptomatic RP after lung SABR, and the predictive model suggests patients with mean non-target lung SUV >-0.56 and MLD > 5.88 Gy EQD2 are at highest risk.

TL;DR: SBRT and radioembolization play key roles in the modern management of patients with CLM who are not eligible for surgery, and patients with limited burden of intrahepatic disease may be ideally suited for SBRT, while those with higher number of CLM may be more appropriate for transarterial radioEmbolization.

TL;DR: In general, the use of DSLF greatly reduces patient setup time and may result in smaller IGRT corrections, and if I GRT is limited, different DSLF setups yield different target coverage and OAR dose sparing.